Targeting Cellular Senescence in Prostate Cancer: Molecular Landscape and Therapeutic Avenues
Haneen Hossam, Bandar Alattaibi
Prostate cancer is one of the major causes of cancer morbidity and mortality in men, especially at advanced stages where treatment fails. Despite the fact that the existing treatment options, such as androgen deprivation therapy, chemotherapy, radiotherapy, PARP inhibitors, and targeted agents, can successfully manage the disease progression, resistance and recurrence are frequent. Recent evidence...
REVIEW | Published: 07 Feb 2026
Annals of Urologic Oncology, Articles, Online First

Submit Manuscript